Cohance Lifesciences consolidated net profit declines 76.01% in the December 2025 quarter
Sales decline 19.47% to Rs 544.55 crore
Net profit of Cohance Lifesciences declined 76.01% to Rs 36.72 crore in the quarter ended December 2025 as against Rs 153.07 crore during the previous quarter ended December 2024. Sales declined 19.47% to Rs 544.55 crore in the quarter ended December 2025 as against Rs 676.23 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales544.55676.23 -19 OPM %17.5135.10 -PBDT92.40248.13 -63 PBT45.46204.57 -78 NP36.72153.07 -76Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 13 2026 | 9:34 AM IST